ArticleAnnals of translational medicine2024
Daily oral ibandronate with adjuvant endocrine therapy in postmenopausal women with estrogen receptor-positive breast cancer: editorial commentary.
Robert ColemanPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.